Recce (Australia) Investor Sentiment

RCE Stock   0.46  0.01  2.13%   
Slightly above 62% of Recce's investor base is looking to short. The analysis of overall sentiment of trading Recce stock suggests that many investors are alarmed at this time. Recce's investing sentiment can be driven by a variety of factors including economic data, Recce's earnings reports, geopolitical events, and overall market trends.
  
over a week ago at news.google.com         
Recce Pharmaceuticals doses all patients in Phase 2 clinical trial of RECCE 327 topical gel for skin...
Google News at Macroaxis
over a month ago at news.google.com         
Recce Pharmaceuticals ready for Phase 3 clinical trial of R327G in diabetic foot infections in Indon...
Google News at Macroaxis
over two months ago at news.google.com         
Recce Pharmaceuticals Highlights Risks and Cautions Investors - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Recce Pharmaceuticals Secures Global Patent for Anti-Infectives - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Recce Pharmaceuticals Advances Phase 3 Trial in Indonesia - MSN
Google News at Macroaxis
over two months ago at news.google.com         
Recce Pharmaceuticals receives A6.75 million RD Tax Incentive rebate By Proactive Investors - Invest...
Google News at Macroaxis
over two months ago at news.google.com         
Recce Pharmaceuticals Gains Momentum with Shareholder Support - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Recce Pharmaceuticals Advances in Promising Skin Infection Trial - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Investors push Recce Pharmaceuticals 13 percent lower this week, companys increasing losses might be...
Google News at Macroaxis
over three months ago at news.google.com         
Recce Pharmaceuticals R327 Gel Shows Promising Trial Results - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Why Fortescue, Lotus Resources, Newmont, and Reece shares are sinking today - The Motley Fool Austra...
Google News at Macroaxis
over three months ago at news.google.com         
Recce From No More Tears to no more superbug fears - Forbes Australia
Google News at Macroaxis
over six months ago at news.google.com         
Recce pharmaceuticals awarded grant to develop burn treatment for US military - Manufactures Monthly
Google News at Macroaxis
over six months ago at news.google.com         
Recce Pharmaceuticals Halts Trading Ahead of Capital Raise - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Those who invested in Recce Pharmaceuticals five years ago are up 170 percent - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Recce that are available to investors today. That information is available publicly through Recce media outlets and privately through word of mouth or via Recce internal channels. However, regardless of the origin, that massive amount of Recce data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Recce news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Recce relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Recce's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Recce alpha.

Recce Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Recce Pharmaceuticals Advances Phase 3 Trial in Indonesia - MSN
11/20/2024
2
Recce Pharmaceuticals doses all patients in Phase 2 clinical trial of RECCE 327 topical gel for skin infections - Investing.com Australia
01/20/2025

Additional Tools for Recce Stock Analysis

When running Recce's price analysis, check to measure Recce's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recce is operating at the current time. Most of Recce's value examination focuses on studying past and present price action to predict the probability of Recce's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recce's price. Additionally, you may evaluate how the addition of Recce to your portfolios can decrease your overall portfolio volatility.